PubMed=16589695; DOI=10.1073/pnas.41.7.432
Puck T.T., Marcus P.I.
A rapid method for viable cell titration and clone production with HeLa cells in tissue culture: the use of X-irradiated cells to supply conditioning factors.
Proc. Natl. Acad. Sci. U.S.A. 41:432-437(1955)

PubMed=13286432; DOI=10.1084/jem.103.2.273
Puck T.T., Marcus P.I., Cieciura S.J.
Clonal growth of mammalian cells in vitro; growth characteristics of colonies from single HeLa cells with and without a feeder layer.
J. Exp. Med. 103:273-283(1956)

PubMed=978597; DOI=10.1269/jrr.17.154
Nikaido O., Horikawa M.
Analysis of the factors in determining radiosensitivity in mammalian cells by using radio-sensitive and -resistant clones isolated from HeLa S3 cells in vitro.
J. Radiat. Res. 17:154-173(1976)

PubMed=566722; DOI=10.1007/BF02616110
Lavappa K.S.
Survey of ATCC stocks of human cell lines for HeLa contamination.
In Vitro 14:469-475(1978)

PubMed=3986962; DOI=10.1093/carcin/6.4.549
Watatani M., Ikenaga M., Hatanaka T., Kinuta M., Takai S.-I., Mori T., Kondo S.
Analysis of N-methyl-N'-nitro-N-nitrosoguanidine (MNNG)-induced DNA damage in tumor cell strains from Japanese patients and demonstration of MNNG hypersensitivity of Mer xenografts in athymic nude mice.
Carcinogenesis 6:549-553(1985)

PubMed=3756862
Maynard K., Parsons P.G.
Cross-sensitivity of methylating agents, hydroxyurea, and methotrexate in human tumor cells of the Mer- phenotype.
Cancer Res. 46:5009-5013(1986)

PubMed=1522048; DOI=10.1007/BF02634140
Kataoka E., Honma M., Ohnishi K., Sofuni T., Mizusawa H.
Application of highly polymorphic DNA markers to the identification of HeLa cell sublines.
In Vitro Cell. Dev. Biol. Anim. 28:553-556(1992)

CLPUB00481
Kuno H., Yoshida T.
Detection of human papillomavirus types 16, 18, and 33 in cell lines derived from human genital organs by polymerase chain reaction.
Res. Commun. Inst. Ferment. Osaka 18:6-12(1997)

PubMed=9290701; DOI=10.1002/(SICI)1098-2744(199708)19:4<243::AID-MC5>3.0.CO;2-D
Jia L.-Q., Osada M., Ishioka C., Gamo M., Ikawa S., Suzuki T., Shimodaira H., Niitani T., Kudo T., Akiyama M., Kimura N., Matsuo M., Mizusawa H., Tanaka N., Koyama H., Namba M., Kanamaru R., Kuroki T.
Screening the p53 status of human cell lines using a yeast functional assay.
Mol. Carcinog. 19:243-253(1997)

DOI=10.11418/jtca1981.17.3_101
Itami C., Ishida R., Utsumi K.R., Nakabayashi T.
Variation in three groups of HeLa cell sublines as revealed by karyotype analysis and O6-methylguaninedna-methyltransferase activity.
Tissue Cult. Res. Commun. 17:101-106(1998)

PubMed=23325432; DOI=10.1101/gr.147942.112
Varley K.E., Gertz J., Bowling K.M., Parker S.L., Reddy T.E., Pauli-Behn F., Cross M.K., Williams B.A., Stamatoyannopoulos J.A., Crawford G.E., Absher D.M., Wold B.J., Myers R.M.
Dynamic DNA methylation across diverse human cell lines and tissues.
Genome Res. 23:555-567(2013)

PubMed=23925245; DOI=10.1038/nature12064
Adey A., Burton J.N., Kitzman J.O., Hiatt J.B., Lewis A.P., Martin B.K., Qiu R., Lee C., Shendure J.
The haplotype-resolved genome and epigenome of the aneuploid HeLa cancer cell line.
Nature 500:207-211(2013)

PubMed=30175587; DOI=10.1021/acs.jproteome.8b00392
Robin T., Bairoch A., Muller M., Lisacek F., Lane L.
Large-scale reanalysis of publicly available HeLa cell proteomics data in the context of the Human Proteome Project.
J. Proteome Res. 17:4160-4170(2018)